Recovery and recurrence following treatment for adolescent major depression

Archives of General Psychiatry

Volumn 68, Issue 3, 2011, Pages 263-270

  Curry, John ^a,b   Silva, Susan ^a,b   Rohde, Paul ^c   Ginsburg, Golda ^d   Kratochvil, Christopher ^e   Simons, Anne ^c   Kirchner, Jerry ^b   May, Diane ^e   Kennard, Betsy ^f   Mayes, Taryn ^f   Feeny, Norah ^g   Albano, Anne Marie ^h   Lavanier, Sarah ⁱ   Reinecke, Mark ^j   Jacobs, Rachel ^j   Becker Weidman, Emily ^j   Weller, Elizabeth ^k   Emslie, Graham ^f   Walkup, John ^d   Kastelic, Elizabeth ^d   Burns, Barbara ^a   Wells, Karen ^a   March, John ^b   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF OREGON   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h NewYork Presbyterian Hospital   (United States)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADOLESCENT; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NATURALISTIC INQUIRY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROBABILITY; RECURRENT DISEASE; SCORING SYSTEM; SEX DIFFERENCE; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT RESPONSE; UNITED STATES;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FLUOXETINE; HUMANS; RECURRENCE; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952320835     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.150     Document Type: Article

References (43)

1. Jane Costello E, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry. 2006;47(12):1263-1271. (Pubitemid 44824722)
2. Birmaher B, Bridge JA, Williamson DE, Brent DA, Dahl RE, Axelson DA, Dorn LD, Ryan ND. Psychosocial functioning in youths at high risk to develop major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2004;43(7):839-846. (Pubitemid 38808489)
3. Gould MS, King R, Greenwald S, Fisher P, Schwab-Stone M, Kramer R, Flisher AJ, Goodman G, Canino G, Shaffer D. Psychopathology associated with suicidal ideation and attempts among children and adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37(9):915-923. (Pubitemid 28406738)
4. Lewinsohn PM, Rohde P, Klein DN, Seeley JR. Natural course of adolescent major depressive disorder, I: continuity into young adulthood. J Am Acad Child Adolesc Psychiatry. 1999;38(1):56-63. (Pubitemid 29022488)
5. Keller MB, Beardslee W, Lavori PW, Wunder J, Drs DL, Samuelson H. Course of major depression in non-referred adolescents: a retrospective study. J Affect Disord. 1988;15(3):235-243. (Pubitemid 18259390)
6. Essau CA. Course and outcome of major depressive disorder in non-referred adolescents. J Affect Disord. 2007;99(1-3):191-201. (Pubitemid 46275036)
7. Lewinsohn PM, Clarke GN, Seeley JR, Rohde P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry. 1994;33(6):809-818. (Pubitemid 24196904)
8. Kovacs M. Presentation and course of major depressive disorder during childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry. 1996; 35(6):705-715. (Pubitemid 26174604)
9. Emslie GJ, Rush AJ, Weinberg WA, Gullion CM, Rintelmann J, Hughes CW. Recurrence of major depressive disorder in hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36(6):785-792. (Pubitemid 27250442)
10. Brent DA, Holder D, Kolko D, Birmaher B, Baugher M, Roth C, Iyengar S, Johnson BA. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry. 1997;54(9):877-885. (Pubitemid 27383316)
11. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54(11): 1031-1037. (Pubitemid 27476099)
12. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Carmody T, Mayes TL. Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depress Anxiety. 1998;7(1):32-39. (Pubitemid 28248517)
13. Clarke GN, Rohde P, Lewinsohn PM, Hops H, Seeley JR. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry. 1999;38(3):272-279. (Pubitemid 29108739)
14. Birmaher B, Brent DA, Kolko D, Baugher M, Bridge J, Holder D, Iyengar S, Ulloa RE. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry. 2000;57(1):29-36. (Pubitemid 30035656)
15. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820. (Pubitemid 39079667)
16. Rohde P, Silva SG, Tonev ST, Kennard BD, Vitiello B, Kratochvil CJ, Reinecke MA, Curry JF, Simons AD, March JS. Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy. Arch Gen Psychiatry. 2008;65(4):447-455. (Pubitemid 351519894)
17. Kennard BD, Silva SG, Tonev S, Rohde P, Hughes JL, Vitiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke MR, March JS. Remission and recovery in the Treatment for Adolescents With Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry. 2009;48(2):186-195.
18. March J, Silva S, Curry J, Wells K, Fairbank J, Burns B, Domino M, Vitiello B, Severe J, Riedal K, Goldman M, Feeny N, Findling R, Stull S, Baab S, Weller EB, Robbins M, Weller RA, Jessani N, Waslick B, Sweeney M, Dublin R, Walkup J, Ginsburg G, Kastelic E, Koo H, Kratochvil C, May D, LaGrone R, Vaughan B, Albano AM, Hirsch GS, Podniesinki E, Chu A, Reincecke M, Leventhal B, Rogers G, Jacobs R, Pathak S, Wells J, Lavanier SA, Danielyan A, Rohde P, Simons A, Grimm J, Frank S, Emslie G, Kennard B, Hughes C, Mayes TL, Rosenberg D, Benazon N, Butkus M, Bartoi M; Treatment for Adolescents With Depression Study (TADS) Team. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry. 2009;166(10):1141-1149.
19. Kennard BD, Silva SG, Mayes TL, Rohde P, Hughes JL, Vitiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke MA, March JS; TADS. Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. Am J Psychiatry. 2009;166(3):337-344.
20. Curry J, Rohde P, Simons A, Silva S, Vitiello B, Kratochvil C, Reinecke M, Feeny N, Wells K, Pathak S, Weller E, Rosenberg D, Kennard B, Robins M, Ginsburg G, March J; TADS Team. Predictors and moderators of acute outcome in the Treatment for Adolescents With Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45(12):1427-1439. (Pubitemid 44900916)
21. PCKendall J, Kessler RC. The impact of childhood psychopathology interventions on subsequent substance abuse: policy implications, comments, and recommendations. J Consult Clin Psychol. 2002;70(6):1303-1306. (Pubitemid 35398520)
22. Treatment for Adolescents With Depression Study (TADS) Team. The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics. J Am Acad Child Adolesc Psychiatry. 2005;44(1):28-40.
23. March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64 (10):1132-1143.
24. Guy W. ECDEU Assessment Manual for Psychopharmacology. 2nd ed. Washington, DC: US Government Printing Office; 1976. DHEW publication ABM 76-388.
25. Poznanski E, Mokros H. Children's Depression Rating Scale-Revised Manual. Los Angeles, CA: Western Psychological Services; 1996.
26. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. Schedule for Affective Disorders and Schizophrenia for School-Age Children- Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988. (Pubitemid 27272932)
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
28. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851-855.
29. Reynolds W. Professional Manual for the Reynolds Adolescent Depression Scale. Odessa, FL: Psychological Assessment Resources; 1987.
30. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-1231. (Pubitemid 13015019)
31. Reynolds W. Professional Manual for the Suicidal Ideation Questionnaire. Odessa, FL: Psychological Assessment Resources; 1987.
32. Beck AT, Steer RA. Manual for the Beck Hopelessness Scale. San Antonio, TX: Psychological Corp; 1993.
33. Leitenberg H, Yost LW, Carroll-Wilson M. Negative cognitive errors in children: questionnaire development, normative data, and comparisons between children with and without self-reported symptoms of depression, low self-esteem, and evaluation anxiety. J Consult Clin Psychol. 1986;54(4):528-536. (Pubitemid 17106004)
34. Prinz RJ. The Assessment of Parent-Adolescent Relations: Discriminating Distressed and Non-distressed Dyads [doctoral dissertation]. Stony Brook: State University of New York; 1977.
35. Wade TJ, Cairney J, Pevalin DJ. Emergence of gender differences in depression during adolescence: national panel results from three countries. J Am Acad Child Adolesc Psychiatry. 2002;41(2):190-198. (Pubitemid 38338168)
36. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106. (Pubitemid 41396935)
37. Lewinsohn PM, Rohde P, Seeley JR, Klein DN, Gotlib IH. Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults. Am J Psychiatry. 2000;157(10):1584-1591.
38. Angold A. Sex and developmental psychopathology. In: Hudziak JJ, ed. Developmental Psychopathology and Wellness: Genetic and Environmental Influences. Arlington, VA: American Psychiatric Publishing; 2008:109-138.
39. Nolen-Hoeksema S, Larson J, Grayson C. Explaining the gender difference in depressive symptoms. J Pers Soc Psychol. 1999;77(5):1061-1072.
40. Clayton PJ, Grove WM, Coryell W, Keller M, Hirschfeld R, Fawcett J. Follow-up and family study of anxious depression. Am J Psychiatry. 1991;148(11):1512-1517.
41. Brown C, Schulberg HC, Madonia MJ, Shear MK, Houck PR. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry. 1996;153(10):1293-1300. (Pubitemid 26334202)
42. Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, Vitiello B, Ritz L, Iyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughes C, DeBar L, McCracken J, Strober M, Suddath R, Spirito A, Leonard H, Melhem N, Porta G, Onorato M, Zelazny J. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901-913. (Pubitemid 351397065)
43. Hughes CW, Emslie GJ, Crismon ML, Posner K, Birmaher B, Ryan N, Jensen P, Curry J, Vitiello B, Lopez M, Shon SP, Pliszka SR, Trivedi MH; Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(6):667-686. (Pubitemid 46816821)